Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 68, Issue 3-4, 1999, Pages 103-109

  Misao, Ryou ^a   Iwagaki, Shigenori ^a   Fujimoto, Jiro ^a   Nakanishi, Yoshihito ^a   Sun, Wen Shu ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gynecologic cancer; Metastatic tumor; mRNA; Sex hormone binding globulin; Splicing variant

Indexed keywords

DNA; ESTRADIOL; MESSENGER RNA; PROGESTERONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENDOMETRIUM CANCER; EXON; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SOUTHERN BLOTTING; UTERINE CERVIX CANCER;

ADULT; AGED; ALTERNATIVE SPLICING; ENDOMETRIAL NEOPLASMS; ESTRADIOL; EXONS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX HORMONE-BINDING GLOBULIN; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 0033054537     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00025-4     Document Type: Article

References (30)

1. Mercier-Bodard C., Alfsen A., Baulieu E.E. Sex steroid binding plasma protein. Acta Endocrinologica. 147:1970;204-224.
2. Strel'chyonok O.A., Avvakumov G.V., Survilo L.I. A recognition system for sex hormone binding protein-estradiol complex in human decidual endometrium plasma membranes. Biochimica et Biophysica Acta. 802:1984;459-466.
3. Nakhla A.M., Khan M.S., Rosner W. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′,5′-monophosphate. Journal of Clinical Endocrinology and Metabolism. 71:1990;398-404.
4. Mercier-Bodard C., Radanyi C., Roux C., Groyer M.T., Robel P., Dadoune J.P., Petra P.H., Jolly D.J., Baulieu E.E. Cellular distribution and hormonal regulation of h-SBP. Journal of Steroid Biochemistry. 27:1987;297-307.
5. Misao R., Itoh N., Mori H., Fujimoto J., Tamaya T. Sex hormone-binding globulin mRNA levels in human uterine endometrium. European Journal of Endocrinology. 131:1994;623-629.
6. Misao R., Nakanishi Y., Ichigo S., Hori M., Fujimoto J., Tamaya T. Expression of sex hormone-binding globulin mRNA in human endometrial cancers. Journal of Steroid Biochemistry and Molecular Biology. 52:1995;517-522.
7. Misao R., Nakanishi Y., Fujimoto J., Hori M., Ichigo S., Tamaya T. Expression of sex hormone-binding globulin mRNA in human ovarian cancers. European Journal of Endocrinology. 133:1995;327-334.
8. Misao R., Nakanishi Y., Fujimoto J., Hori M., Ichigo S., Tamaya T. Expression of sex hormone-binding globulin mRNA in uterine cervical cancers. Tumor Biology. 18:1997;6-12.
9. Hammond G.L., Underhill D.A., Rykse H.M., Smith C.L. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Molecular Endocrinology. 3:1989;1869-1876.
10. Petra P.H. The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function. Journal of Steroid Biochemistry and Molecular Biology. 40:1991;735-753.
11. Misao R., Nakanishi Y., Fujimoto J., Tamaya T. Expression of sex hormone-binding globulin exon VII splicing variant messenger RNA in human uterine endometrial cancers. Cancer Research. 57:1997;5579-5583.
12. Misao R., Nakanishi Y., Fujimoto J., Tamaya T. Relatively high expression of sex hormone-binding globulin exon VII splicing variant to wild-type mRNA in human uterine cervical cancers. Japanese Journal of Cancer Research. 89:1998;47-52.
13. Misao R., Nakanishi Y., Fujimoto J., Iwagaki S., Tamaya T. Dominant expression of sex hormone-binding globulin exon 7 splicing variant over wild-type mRNA in human ovarian cancers. International Journal of Cancer. 77:1998;828-832.
14. News. International Journal of Gynecology and Obstetrics. 28:1989;189-193.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
16. Arcali P., Martinelli R., Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Research. 12:1984;9179-9189.
17. Clark J.H., Schrader W.T., O'Malley B.W. Mechanism of action of steroid hormone. Wilson J.D., Foster D.W. Williams Textbook of Endocrinology. 8th ed. 1992;35-90 W.B. Saunders, Philadelphia.
18. Lippman M.E., Swain S.M. Endocrine-responsive cancers of human. Wilson J.D., Foster D.W. Williams Textbook of Endocrinology. 8th ed. 1992;1577-1597 W.B. Saunders, Philadelphia.
19. Jikihara H., Terada N., Yamamoto R., Nishikawa Y., Tanizawa O., Matsumoto K., Terakawa N. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. American Journal of Obstetrics and Gynecology. 167:1992;207-211.
20. Fujimoto J., Hori M., Ichigo S., Morishita S., Tamaya T. Estrogen activates migration potential of endometrial cancer cells through basement membrane. Tumor Biology. 17:1996;48-57.
21. Vihko R., Isotalo H., Kauppila A., Vierikko P. Female sex steroid receptors in gynecological malignancies: clinical correlates. Journal of Steroid Biochemistry. 19:1983;827-832.
22. Gao Y.L., Twiggs L.B., Leung B.S., Yu W.C.Y., Potish R.A., Okagaki T., Adcock L.L., Prem K.A. Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates. American Journal of Obstetrics and Gynecology. 146:1983;299-306.
23. Quinn M.A., Rome R.M., Cauchi M., Fortune D.W. Steroid receptors and ovarian tumors: variation within primary tumors and between primary tumors and metastases. Gynecologic Oncology. 31:1988;424-429.
24. Runowicz C.D., Nuchtern L.M., Braunstein J.D., Jones J.G. Heterogeneity in hormone receptor status in primary and metastatic endometrial cancer. Gynecologic Oncology. 38:1990;437-441.
25. Fuqua S.A.W., Fitzgerald S.D., Chamness G.C., Tandon A.K., McDonnell D.P., Nawaz Z., O'Malley B.W., McGuire W.L. Variant human breast estrogen receptor with constitutive transcriptional activity. Cancer Research. 51:1991;105-109.
26. Fujimoto J., Ichigo S., Hirose R., Hori M., Tamaya T. Expression of estrogen receptor exon 5 splicing variant (ER E5SV) mRNA in gynecological cancers. Journal of Steroid Biochemistry and Molecular Biology. 60:1997;25-30.
27. Fujimoto J., Ichigo S., Hori M., Nishigaki M., Tamaya T. Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. Tumor Biology. 16:1995;254-260.
28. Mangal R.K., Wiehle R.D., Poindexer A.N. III, Weigel N.L. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. Journal of Steroid Biochemistry and Molecular Biology. 63:1997;195-202.
29. Vegate E., Shabaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Molecular Endocrinology. 7:1993;1244-1255.
30. Fujimoto J., Ichigo S., Hirose R., Sakaguchi H., Tamaya T. Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers. Journal of Steroid Biochemistry and Molecular Biology. 62:1997;449-454.